Addressing the Challenges in Using Synthetic Data for Health Research: Application to Cardiology

Area of Science:

• Cardiology
• Data Science
• Bioethics

Background:

• Synthetic data generation offers significant potential for advancing cardiology research by enabling secure data sharing, enhancing patient privacy, and facilitating machine learning model development.
• Artificial patient records mirroring real-world distributions can accelerate clinical research, improve model performance for rare cardiovascular conditions, and overcome data-sharing barriers in transnational collaborations.

Purpose of the Study:

• To highlight the critical need for addressing ethical, regulatory, and methodological concerns surrounding the increasing use of synthetic data in cardiology.
• To advocate for clear differentiation between synthetic data used as a privacy-preserving distributional substitute and as a counterfactual simulation tool.
• To propose fit-for-purpose governance frameworks for the responsible integration of synthetic data in cardiology research and product evaluation.

Main Methods:

• Conceptual analysis differentiating the two primary roles of synthetic data: distributional substitute (statistical fidelity) and counterfactual simulation (novel scenario generation).
• Review of current regulatory landscapes (GDPR, HIPAA) and their limitations in addressing synthetic data risks like reidentification and data leakage.
• Proposal of a 4-action framework for the cardiology research community: mandatory 3-layer validation (fidelity, utility, privacy), systematic subgroup reporting, explicit intended-use scoping, and domain-specific acceptability thresholds.

Main Results:

• Current regulatory frameworks are insufficient for governing synthetic data, lacking harmonized guidance for its use as stand-alone evidence.
• The distinct methodological requirements and failure modes for synthetic data as a distributional substitute versus a counterfactual simulation tool are often conflated.
• Failure to distinguish these roles can lead to inadequate representation of complex populations and amplification of existing biases in cardiovascular care.

Conclusions:

• Responsible integration of synthetic data in cardiology necessitates clear conceptualization of its intended use and robust governance frameworks.
• Rigorous, adversary-aware privacy evaluation alongside utility and fidelity testing is essential before accepting synthetic data as evidence.
• Adoption of proposed actions will enhance the validity, generalizability, and ethical application of synthetic data in cardiovascular research and innovation.